Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Altered likelihood of brain activation in attention and working memory networks in patients with multiple sclerosis: An ALE meta-analysis.
Circulating monocytes are reduced by sphingosine-1-phosphate receptor modulators independently of S1P3.
4-Aminopyridine ameliorates mobility but not disease course in an animal model of multiple sclerosis.
Teaching NeuroImages: MRI in advanced neuromyelitis optica.
Daclizumab (anti-CD25) in multiple sclerosis.
Genetics of multiple sclerosis: swimming in an ocean of data.
Stress Management and Multiple Sclerosis: A Randomized Controlled Trial.
Apitope Announces Positive Results from Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
Single-use autoinjector for peginterferon-β1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study.
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H).
Recombinant T cell receptor ligands: immunomodulatory, neuroprotective and neuroregenerative effects suggest application as therapy for multiple sclerosis.
Guillain-Barré syndrome: clinical profile and management.
Role of the Blood-Brain Barrier in Multiple Sclerosis.
Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies.
Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)
Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results.
Pediatric multiple sclerosis.
Novartis gains approval for Gilenya® as a first-line disease modifying oral therapy for multiple sclerosis in Switzerland and Australia
Teva Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE(R) Patent
Punctate pattern: A promising imaging marker for the diagnosis of natalizumab-associated PML.
Activation of axonal Kv7 channels in human peripheral nerve by flupirtine but not placebo - therapeutic potential for peripheral neuropathies: results of a randomised controlled trial.
Rare variants in the CYP27B1 gene are associated with multiple sclerosis.
SIRT1 deacetylates RORγt and enhances Th17 cell generation.
Interferon β-1a reduces increased interleukin-16 levels in multiple sclerosis patients.
Comparing the biological impact of glatiramer acetate with the biological impact of a generic.

Pages